BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Deals

  Rumor Has Terumo Eyeing Abbott’s Cardio Biz

  September 30, 2016

   · 

  1 min read
• Drug Development

  Regeneron Faces Setback as Eylea Combo Drug Flunks Phase II Test

  September 30, 2016

   · 

  9 min read
• Biotech Bay

  Will Programmable Immune “Cellbots” Be the Next Weapon Against Cancer? UCSF Study

  September 30, 2016

   · 

  1 min read
• Bio NC

  Cell Culture Agtech Offers Prospect Of Meat And Milk Without The Moo, North Carolina State University Study

  September 30, 2016

   · 

  1 min read
• BioCapital

  When A Nobel Prize Brings A Shower Of Hype: The Roller Coaster Ride Of RNAi

  September 30, 2016

   · 

  1 min read
• Biotech Bay

  Amgen’s Backup Plan For Kyprolis Flop

  September 30, 2016

   · 

  1 min read
• Biotech Bay

  Amgen Maintains Migraine Drug Lead

  September 30, 2016

   · 

  1 min read
• Genetown

  Will CE Mark For Boston Scientific’s Lotus Edge Impact The TAVR Market?

  September 30, 2016

   · 

  1 min read
• Policy

  Teva Alleges Fraud By Rimsa’s Previous Owners

  September 30, 2016

   · 

  1 min read
• BioMidwest

  Bony Biomaterial May Keep Kids From Outgrowing Their Implants, Northwestern University Study

  September 30, 2016

   · 

  1 min read